文献速递心律失常

新诊断房颤的治疗专科与结局:TREAT-AF研究

Treating Specialty and Outcomes in Newly Diagnosed Atrial Fibrillation: From the TREAT-AF Study.
PubMed 文献 · J Am Coll Cardiol · 2017-01-01

基于退伍健康管理局TREAT-AF研究,纳入2004至2012年新诊断非瓣膜性房颤且有早期门诊接触的患者,比较心内科与初级保健诊疗与结局的关联。心内科诊疗与卒中及死亡风险降低相关,但房颤/室上速住院和心肌梗死风险增加,早期口服抗凝可能介导卒中减少。

要点

  • 新诊断房颤患者中,心内科诊疗与卒中及死亡风险降低相关。
  • 心内科诊疗同时与房颤/室上速住院和心肌梗死风险增加相关。
  • 早期口服抗凝可能介导卒中减少,但未介导生存改善。

核心结论

  • 新诊断房颤患者接受心内科诊疗与改善的结局相关,可能由早期口服抗凝治疗介导。

研究设计与样本

  • 回顾性队列研究,使用TREAT-AF研究数据,纳入2004至2012年新诊断非瓣膜性房颤且诊断后90天内有初级保健或心内科门诊接触的患者。
  • 共纳入184,161例患者,年龄70±11岁,女性占1.7%,CHA2DS2-VASc评分2.6±1.7。
  • 40%接受心内科诊疗,60%仅接受初级保健。
  • 采用Cox比例风险回归评估治疗专科与房颤结局的关联,并进行倾向性匹配和中介分析。

主要发现

  • 调整协变量后,心内科诊疗与卒中风险降低相关(HR 0.91;95%CI 0.86-0.96;p<0.001)。
  • 心内科诊疗与死亡风险降低相关(HR 0.89;95%CI 0.88-0.91;p<0.0001)。
  • 心内科诊疗与房颤/室上性心动过速住院风险增加相关(HR 1.38;95%CI 1.35-1.42;p<0.0001)。
  • 心内科诊疗与心肌梗死风险增加相关(HR 1.03;95%CI 1.00-1.05;p<0.04)。
  • 倾向性匹配队列结果相似;中介分析显示诊断后90天内口服抗凝处方可能介导卒中减少,但未介导生存改善。

临床怎么用

  • 新诊断房颤患者可考虑心内科参与诊疗,以可能降低卒中和死亡风险。
  • 应关注心内科诊疗患者中房颤/室上速住院和心肌梗死风险增加的现象。
  • 早期启动口服抗凝可能是心内科诊疗获益的重要环节。

局限性

  • 研究为回顾性设计,结果具有假设生成性,需进一步研究验证。
  • 数据来自退伍健康管理局人群,以男性为主(女性仅1.7%),外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Atrial fibrillation (AF) occurs in many clinical contexts and is diagnosed and treated by clinicians across many specialties. This approach has resulted in treatment variations. OBJECTIVES: The goal of this study was to evaluate the association between treating specialty and AF outcomes among patients newly diagnosed with AF. METHODS: Using data from the TREAT-AF (Retrospective Evaluation and Assessment of Therapies in AF) study from the Veterans Health Administration, patients with newly diagnosed, nonvalvular AF between 2004 and 2012 were identified who had at least 1 outpatient encounter with primary care or cardiology within 90 days of the AF diagnosis. Cox proportional hazards regression was used to evaluate the association between treating specialty and AF outcomes. RESULTS: Among 184,161 patients with newly diagnosed AF (age 70 ± 11 years; 1.7% women; CHA2DS2-VASc score 2.6 ± 1.7), 40% received cardiology care and 60% received primary care only. After adjustment for covariates, cardiology care was associated with reductions in stroke (hazard ratio [HR]: 0.91; 95% confidence interval [CI]: 0.86 to 0.96; p < 0.001) and death (HR: 0.89; 95% CI: 0.88 to 0.91; p < 0.0001) and increases in hospitalizations for AF/supraventricular tachycardia (HR: 1.38; 95% CI: 1.35 to 1.42; p < 0.0001) and myocardial infarction (HR: 1.03; 95% CI: 1.00 to 1.05; p < 0.04). The propensity-matched cohort had similar results. In mediation analysis, oral anticoagulation prescription within 90 days of diagnosis may have mediated reductions in stroke but did not mediate reductions in survival. CONCLUSIONS: In patients with newly diagnosed AF, cardiology care was associated with improved outcomes, potentially mediated by early prescription of oral anticoagulation therapy. Although hypothesis-generating, these data warrant serious consideration and study of health care system interventions at the time of new AF diagnosis.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Perino AC, Fan J, Schmitt SK, et al. Treating Specialty and Outcomes in Newly Diagnosed Atrial Fibrillation: From the TREAT-AF Study. J Am Coll Cardiol. 2017. PMID: 28662810. doi:10.1016/j.jacc.2017.04.054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。